Safety of anesthesia for children with mucopolysaccharidoses: A retrospective analysis of 54 patients
暂无分享,去创建一个
A. Zanella | A. Pesenti | R. Parini | V. Scaravilli | S. Gasperini | Alessia La Bruna | M. Bosatra | C. Flandoli | S. Sosio | Valentina Ciceri | Alessandra Moretto
[1] Alireza Alizadeh-Ghavidel,et al. Blood Transfusion Practice in a Referral Cardiovascular Center in Tehran, Iran: A Critical Point of View , 2014, Research in cardiovascular medicine.
[2] N. Jansen,et al. Anesthetic Challenges in an Adult with Mucopolysaccharidosis Type VI. , 2014, A & A case reports.
[3] J. Graaff,et al. Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age , 2014, Paediatric anaesthesia.
[4] R. Azarfarin,et al. Management of Difficult Airway With Laryngeal Mask in a Child With Mucopolysaccharidosis and Mitral Regurgitation: A Case Report , 2014, Research in cardiovascular medicine.
[5] Y. Tamaki,et al. Risk factors with intravenous sedation for patients with disabilities. , 2013, Anesthesia progress.
[6] J. Muenzer,et al. Bronchoscopy and airway management in patients with mucopolysaccharidoses (MPS) , 2013, Pediatric pulmonology.
[7] I. Bruce,et al. Anaesthesia and airway management in mucopolysaccharidosis , 2012, Journal of Inherited Metabolic Disease.
[8] J. Yaplito-Lee,et al. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses , 2012, Paediatric anaesthesia.
[9] R. Walker,et al. Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management , 2012, Paediatric anaesthesia.
[10] L. Grigull,et al. Paediatric airway management in mucopolysaccharidosis 1: a retrospective case review , 2012, European journal of anaesthesiology.
[11] H. W. Webb,et al. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry. , 2012, Journal of pediatric surgery.
[12] L. de Meirleir,et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease , 2011, Orphanet journal of rare diseases.
[13] A. Kaye,et al. Mucopolysaccharidoses: anesthetic considerations and clinical manifestations. , 2011, Middle East journal of anaesthesiology.
[14] P. Arn,et al. Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry. , 2009, The Journal of pediatrics.
[15] Joseph P Cravero,et al. The Incidence and Nature of Adverse Events During Pediatric Sedation/Anesthesia With Propofol for Procedures Outside the Operating Room: A Report From the Pediatric Sedation Research Consortium , 2009, Anesthesia and analgesia.
[16] A. Bekker,et al. Anesthesia for an adult with mucopolysaccharidosis I. , 2005, Journal of clinical anesthesia.
[17] Joseph Muenzer,et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). , 2004, The Journal of pediatrics.
[18] F. Cecere,et al. Anaestethic problems in Sanfilippo syndrome. A rare case of adult patient. , 2003, Minerva anestesiologica.
[19] D. Notterman,et al. Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation , 2000, Pediatrics.
[20] P. Busoni,et al. Failure of the laryngeal mask to secure the airway in a patient with Hunter's syndrome (mucopolysaccharidosis type II) , 1999, Paediatric anaesthesia.
[21] D. Baines,et al. Anaesthetic Implications of the Mucopolysaccharidoses: A Fifteen-Year Experience in a Children's Hospital , 1983, Anaesthesia and intensive care.
[22] T. Brown,et al. Anaesthesia and the Mucopolysaccharidoses: A Survey of Techniques and Problems , 1983, Anaesthesia and intensive care.
[23] A. Barrett,et al. Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantation , 1982, Journal of Inherited Metabolic Disease.
[24] Y. Beyth,et al. ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.
[25] I. Herrick,et al. The mucopolysaccharidoses and anaesthesia: a report of clinical experience , 1988, Canadian journal of anaesthesia = Journal canadien d'anesthesie.